Clinical trials
Phase 4 HIV Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
156 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 6 |
| 2003 | 6 |
| 2004 | 10 |
| 2005 | 20 |
| 2006 | 13 |
| 2007 | 7 |
| 2008 | 20 |
| 2009 | 13 |
| 2010 | 8 |
| 2011 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
| Terminated | 16 |
| Unknown status | 11 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 9 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| University of California, San Francisco | 9 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 5 |
| Bristol-Myers Squibb | 5 |
| Glaxo Wellcome | 5 |
| University of North Carolina, Chapel Hill | 5 |
| ViiV Healthcare | 5 |
| Community Research Initiative of New England | 4 |
| Gilead Sciences | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 156 |
| Acquired Immunodeficiency Syndrome | 33 |
| Hepatitis C | 7 |
| Lipodystrophy | 7 |
| Opioid-Related Disorders | 5 |
| Cardiovascular Diseases | 4 |
| Insulin Resistance | 4 |
| Cytomegalovirus Infections | 3 |
| Dyslipidemias | 3 |
| Hepatitis B | 3 |
Trials
Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.
56 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.